Published in Trans R Soc Trop Med Hyg on March 07, 1990
Purification and characterization of oligomeric envelope glycoprotein from a primary R5 subtype B human immunodeficiency virus. J Virol (2002) 1.54
Serodiagnosis of parasitic diseases. Clin Microbiol Rev (1991) 0.92
Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease. J Clin Invest (1976) 5.96
New controlling element in the Lac operon of E. coli. Nature (1968) 4.63
Mutational alteration of the maximal level of Lac operon expression. Cold Spring Harb Symp Quant Biol (1966) 3.71
Plasma immunoglobulin concentrations in a West African (Gambian) community and in a group of healthy British adults. Clin Exp Immunol (1968) 3.53
Malaria infection of the placenta in The Gambia, West Africa; its incidence and relationship to stillbirth, birthweight and placental weight. Trans R Soc Trop Med Hyg (1983) 3.46
Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell (1993) 3.41
Epidemiology, malaria and pregnancy. Am J Trop Med Hyg (1984) 3.32
Bacterial transcript imaging by hybridization of total RNA to oligonucleotide arrays. Nat Biotechnol (1998) 3.29
Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol (1992) 3.12
Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis. J Clin Invest (1975) 2.97
Antibodies to sporozoites: their frequent occurrence in individuals living in an area of hyperendemic malaria. Science (1979) 2.91
F-prime factor formation in E. coli K12. Genet Res (1966) 2.80
The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of Plasmodium falciparum sporozoites. Cell (1992) 2.78
Major surface antigen gene of a human malaria parasite cloned and expressed in bacteria. Nature (1984) 2.74
Transcript imaging of the development of human T helper cells using oligonucleotide arrays. Nat Genet (2000) 2.71
Domain organization and molecular characterization of 13 two-component systems identified by genome sequencing of Streptococcus pneumoniae. Gene (1999) 2.68
The radial forearm flap: a versatile method for intra-oral reconstruction. Br J Plast Surg (1983) 2.61
Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of hepatocytes. J Exp Med (1993) 2.60
Rapid and label-free nanomechanical detection of biomarker transcripts in human RNA. Nat Nanotechnol (2006) 2.53
Immunity to asexual erythrocytic stages of Plasmodium falciparum: role of defined antigens in the humoral response. Immunol Rev (1982) 2.49
Antigens associated with Plasmodium falciparum infections in man. Lancet (1969) 2.45
Episomes. Annu Rev Microbiol (1967) 2.36
Plasmodium falciparum strain-specific antibody blocks binding of infected erythrocytes to amelanotic melanoma cells. Nature (1983) 2.32
The groin flap. Br J Plast Surg (1972) 2.30
Identification of a single promoter in E. coli for rplJ, rplL and rpoBC. Nature (1978) 2.22
Antimalarial immunity in Saimiri monkeys. Immunization with surface components of asexual blood stages. J Exp Med (1984) 2.16
Maternal grandmothers improve nutritional status and survival of children in rural Gambia. Proc Biol Sci (2000) 2.06
Inhibition of P. falciparum growth in human erythrocytes by monoclonal antibodies. Nature (1981) 2.05
Subregions of a conserved part of the HIV gp41 transmembrane protein are differentially recognized by antibodies of infected individuals. EMBO J (1986) 2.01
Antigens of the erythrocytes stages of the human malaria parasite Plasmodium falciparum detected by monoclonal antibodies. Mol Biochem Parasitol (1983) 2.00
Identification of a CD4 binding site on the beta 2 domain of HLA-DR molecules. Nature (1992) 1.98
Growth and Mortality in Children in an African Village. Br Med J (1961) 1.95
Hepatitis B virus infection in two Gambian villages. Lancet (1983) 1.92
Season of birth predicts mortality in rural Gambia. Nature (1997) 1.85
Purification and characterization of recombinant human p50csk protein-tyrosine kinase from an Escherichia coli expression system overproducing the bacterial chaperones GroES and GroEL. Proc Natl Acad Sci U S A (1995) 1.78
Identification of a motif for HLA-DR1 binding peptides using M13 display libraries. J Exp Med (1992) 1.78
Evidence for a lambda transducing phage carrying the genes for the beta and beta' subunits of Escherichia coli RNA polymerase. Mol Gen Genet (1974) 1.75
Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV. J Infect Dis (1998) 1.72
Polymorphism of the precursor for the major surface antigens of Plasmodium falciparum merozoites: studies at the genetic level. EMBO J (1985) 1.69
Enzyme variation in Plasmodium falciparum in the Gambia. Trans R Soc Trop Med Hyg (1973) 1.68
A new method for selecting RNA polymerase mutants. J Mol Biol (1970) 1.68
Prenatal or early postnatal events predict infectious deaths in young adulthood in rural Africa. Int J Epidemiol (1999) 1.63
The radial forearm flap in intraoral reconstruction: the experience of 60 consecutive cases. Plast Reconstr Surg (1986) 1.63
Yeast may not contain histone H1: the only known 'histone H1-like' protein in Saccharomyces cerevisiae is a mitochondrial protein. Nucleic Acids Res (1984) 1.61
Characterisation of a repetitive DNA sequence from the malaria parasite, Plasmodium falciparum. Mol Biochem Parasitol (1986) 1.61
The demography of two West African (Gambian) villages, 1951--75. J Biosoc Sci (1981) 1.60
Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum. Infect Immun (1991) 1.60
Nucleotide sequence of the prokaryotic mobile genetic element IS30. EMBO J (1984) 1.59
Mechanism of injury of virus-infected cells by antiviral antibody and complement: participation of IgG, F(ab')2, and the alternative complement pathway. J Exp Med (1976) 1.57
Axial and random pattern flaps. Br J Plast Surg (1973) 1.55
Incidence of hepatitis C, hepatitis B and HIV infections among drug users in a methadone-maintenance programme. AIDS (1992) 1.55
Symptomatic primary infection due to human immunodeficiency virus type 1: review of 31 cases. Clin Infect Dis (1993) 1.52
Soluble antigens in the blood of African patients with severe plasmodium falciparum malaria. Lancet (1968) 1.50
Selection of T cell epitopes and vaccine engineering. Methods Enzymol (1991) 1.50
A malaria protein exported into a new compartment within the host erythrocyte. EMBO J (1987) 1.49
Effects of temperature and single-stranded DNA on the interaction of an RNA polymerase III transcription factor with a tRNA gene. Cell (1985) 1.47
The health of young children in a West African (Gambian) village. Trans R Soc Trop Med Hyg (1970) 1.46
Protection against malaria in Aotus monkeys immunized with a recombinant blood-stage antigen fused to a universal T-cell epitope: correlation of serum gamma interferon levels with protection. Infect Immun (1992) 1.45
Rearrangements of genetic material in Escherichia coli as observed on the bacteriophage P1 plasmid. Cold Spring Harb Symp Quant Biol (1979) 1.44
The complete sequence of a Plasmodium malariae SSUrRNA gene and its comparison to other plasmodial SSUrRNA genes. Mol Biochem Parasitol (1991) 1.44
Immunization with a Plasmodium falciparum merozoite surface antigen induces a partial immunity in monkeys. J Clin Invest (1985) 1.43
Plasma immunoglobulin concentrations in an African (Gambian) community in relation to season, malaria and other infections and pregnancy. Clin Exp Immunol (1970) 1.43
Agglutination of Plasmodium falciparum-infected erythrocytes from east and west African isolates by human sera from distant geographic regions. Am J Trop Med Hyg (1992) 1.41
Successful prophylaxis with tinidazole of infection after major head and neck surgery for malignant disease. Br J Plast Surg (1984) 1.41
Immunology of malarial infection and its possible consequences. Br Med Bull (1972) 1.39
Epidemiological studies of rubella virus in a tropical African community. Bull World Health Organ (1980) 1.39
The growth of young children in a Gambian village. Trans R Soc Trop Med Hyg (1968) 1.39
Opsonic activity of human immune serum on in vitro phagocytosis of Plasmodium falciparum infected red blood cells by monocytes. Clin Exp Immunol (1982) 1.39
Demonstration of circulating antibodies to Plasmodium falciparum by gel-diffusion techniques. Nature (1966) 1.38
Heritability of stature in a West African population. Ann Hum Genet (1978) 1.35
Co-localization of GABA receptors and benzodiazepine receptors in the brain shown by monoclonal antibodies. Nature (1985) 1.35
Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus. J Immunol (1988) 1.33
A birth-to-maturity longitudinal study of heights and weights in two West African (Gambian) villages, 1951-1975. Ann Hum Biol (1982) 1.32
Circulating and tissue-bound immune complex formation in murine malaria. J Immunol (1979) 1.32
Immunization with synthetic peptides of a Plasmodium falciparum surface antigen induces antimerozoite antibodies. Proc Natl Acad Sci U S A (1986) 1.32
Efficient control of gene expression by single step integration of the tetracycline system in transgenic mice. Nat Biotechnol (1996) 1.32
Nonpolymorphic regions of p190, a protein of the Plasmodium falciparum erythrocytic stage, contain both T and B cell epitopes. J Immunol (1988) 1.31
Hemagglutinins in sera of Africans of Gambia. Proc Soc Exp Biol Med (1968) 1.31
Crystal structure of Escherichia coli lytic transglycosylase Slt35 reveals a lysozyme-like catalytic domain with an EF-hand. Structure (1999) 1.29
Assessment in humans of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, Plasmodium falciparum. J Immunol (1988) 1.28
Quantitation of C3PA (properdin factor B) and other complement components in diseases associated with a low C3 level. Clin Immunol Immunopathol (1973) 1.28
Restriction site-free insertion of PCR products directionally into vectors. Biotechniques (2000) 1.28
Immunization of Aotus monkeys with Plasmodium falciparum blood-stage recombinant proteins. Proc Natl Acad Sci U S A (1990) 1.28
Immunologic injury in measles virus infection. III. Presence and characterization of human cytotoxic lymphocytes. J Immunol (1977) 1.27
Phagocytosis of Plasmodium falciparum-parasitized erythrocytes by human polymorphonuclear leukocytes. J Parasitol (1983) 1.26
The extended role of the delto-pectoral flap. Br J Plast Surg (1970) 1.26
Limiting dilution assay for human B cells based on their activation by mutant EL4 thymoma cells: total and antimalaria responder B cell frequencies. Eur J Immunol (1987) 1.26
Plasma immunoglobulin concentrations in mothers and newborn children with special reference to placental malaria: Studies in the Gambia, Nigeria, and Switzerland. Bull World Health Organ (1973) 1.23
The anatomical basis of the groin flap. Plast Reconstr Surg (1972) 1.22
Rapid clearance of malaria circumsporozoite protein (CS) by hepatocytes. J Exp Med (1994) 1.22
Characterisation and sequence of a protective rhoptry antigen from Plasmodium falciparum. Mol Biochem Parasitol (1990) 1.22
A rhoptry antigen of Plasmodium falciparum is protective in Saimiri monkeys. Parasitology (1990) 1.21
Value of the gel-precipitation test in monitoring the endemicity of malaria in a rural African village. Isr J Med Sci (1978) 1.21
Cloning and expression in Escherichia coli of a surface antigen of Plasmodium falciparum merozoites. EMBO J (1985) 1.20